Distribution of capsular and surface polysaccharide serotypes of Staphylococcus aureus

Diagnostic Microbiology and Infectious Disease

Volumn 58, Issue 3, 2007, Pages 297-302

  von Eiff, Christof ^a   Taylor, Kimberly L ^b   Mellmann, Alexander ^a   Fattom, Ali I ^b   Friedrich, Alexander W ^a   Peters, Georg ^a   Becker, Karsten ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Nabi Biopharmaceuticals   (United States)

Author keywords

Capsular polysaccharide; MRSA; Prevention; Serotypes; Spa typing; Staphylococcus aureus; Surface polysaccharide; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL POLYSACCHARIDE; CAPSULAR POLYSACCHARIDE; OXACILLIN; RNA 16S; STAPHYLOCOCCUS VACCINE; SURFACE POLYSACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOOD; CLINICAL ARTICLE; GERMANY; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTYPE; SPA GENE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE; VACCINE PRODUCTION;

AGGLUTINATION TESTS; GERMANY; HOSPITALS; HUMANS; IMMUNODIFFUSION; POLYSACCHARIDES, BACTERIAL; SEROTYPING; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 34347323824     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.01.016     Document Type: Article

References (33)

1. Arbeit R.D., Karakawa W.W., Vann W.F., and Robbins J.B. Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus. Diagn. Microbiol. Infect Dis. 2 (1984) 85-91
2. Becker K., Harmsen D., Mellmann A., Meier C., Schumann P., Peters G., and von Eiff C. Development and evaluation of a quality-controlled ribosomal sequence database for 16S rDNA-based identification of Staphylococcus species. J. Clin. Microbiol. 42 (2004) 4988-4995
3. Cocchiaro J.L., Gomez M.I., Risley A., Solinga R., Sordelli D.O., and Lee J.C. Molecular characterization of the capsule locus from non-typeable Staphylococcus aureus. Mol. Microbiol. 59 (2006) 948-960
4. Essawi T., Na'was T., Hawwari A., Wadi S., Doudin A., and Fattom A.I. Molecular, antibiogram and serological typing of Staphylococcus aureus isolates recovered from Al-Makased Hospital in East Jerusalem. Trop. Med. Int. Health 3 (1998) 576-583
5. Fattom A., and Guidry A. Questions uniqueness of surface polysaccharide-respond. Am. J. Vet. Res. 60 (1999) 530
6. Fattom A., Schneerson R., Szu S.C., Vann W.F., Shiloach J., Karakawa W.W., and Robbins J.B. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa exotoxin A. Infect. Immun. 58 (1990) 2367-2374
7. Fattom A., Schneerson R., Watson D.C., Karakawa W.W., Fitzgerald D., Pastan I., Li X., Shiloach J., Bryla D.A., and Robbins J.B. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A. Infect. Immun. 61 (1993) 1023-1032
8. Fattom A., Fuller S., Propst M., Winston S., Muenz L., He D., Naso R., and Horwith G. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. Vaccine 23 (2004) 656-663
9. Fattom A.I., Horwith G., Fuller S., Propst M., and Naso R. Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials. Vaccine 22 (2004) 880-887
10. Fournier J.M., Bouvet A., Boutonnier A., Audurier A., Goldstein F., Pierre J., Bure A., Lebrun L., and Hochkeppel H.K. Predominance of capsular polysaccharide type 5 among oxacillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 25 (1987) 1932-1933
11. Friedrich A.W., Witte W., Harmsen D., de Lencastre H., Hryniewicz W., Scheres J., and Westh H. SeqNet.org: a European laboratory network for sequence-based typing of microbial pathogens. Euro. Surveill. 11 (2006) E060112
12. Gilbert I. Dissociation in an encapsulated Staphylococcus. J. Bacteriol. 21 (1931) 157-160
13. Grundmann H., Aires-de-Sousa M., Boyce J., and Tiemersma E. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368 (2006) 874-885
14. Guidry A., Fattom A., Patel A., O'Brien C., Shepherd S., and Lohuis J. Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis. Am. J. Vet. Res. 59 (1998) 1537-1539
15. Harmsen D., Claus H., Witte W., Rothganger J., Claus H., Turnwald D., and Vogel U. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J. Clin. Microbiol. 41 (2003) 5442-5448
16. Hochkeppel H.K., Braun D.G., Vischer W., Imm A., Sutter S., Staeubli U., Guggenheim R., Kaplan E.L., Boutonnier A., and Fournier J.M. Serotyping and electron microscopy studies of Staphylococcus aureus clinical isolates with monoclonal antibodies to capsular polysaccharide types 5 and 8. J. Clin. Microbiol. 25 (1987) 526-530
17. Karakawa W.W., Fournier J.M., Vann W.F., Arbeit R., Schneerson R.S., and Robbins J.B. Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus. J. Clin. Microbiol. 22 (1985) 445-447
18. Karakawa W.W., and Vann W.F. Capsular polysaccharides of Staphylococcus aureus. Sem. Infect. Dis. 4 (1982) 285-293
19. Mellmann A., Friedrich A.W., Rosenkotter N., Rothganger J., Karch H., Reintjes R., and Harmsen D. Automated, DNA sequence-based early warning system for the detection of methicillin-resistant Staphylococcus aureus outbreaks. PLoS Med. 3 (2006) e33
20. Na'was T., Hawwari A., Hendrix E., Hebden J., Edelman R., Martin M., Campbell W., Naso R., Schwalbe R., and Fattom A.I. Phenotypic and genotypic characterization of nosocomial Staphylococcus aureus isolates from trauma patients. J. Clin. Microbiol. 36 (1998) 414-420
21. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J., Johnson S.K., Vandenesch F., Fridkin S., O'Boyle C., Danila R.N., and Lynfield R. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290 (2003) 2976-2984
22. Nilsson I.M., Lee J.C., Bremell T., Ryden C., and Tarkowski A. The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect. Immun. 65 (1997) 4216-4221
23. O'Brien C.N., Guidry A.J., Fattom A., Shepherd S., Douglass L.W., and Westhoff D.C. Production of antibodies to Staphylococcus aureus serotypes 5, 8, and 336 using poly(dl-lactide-co-glycolide) microspheres. J. Dairy Sci. 83 (2000) 1758-1766
24. Robbins J.B., Schneerson R., Horwith G., Naso R., and Fattom A. Staphylococcus aureus types 5 and 8 capsular polysaccharide-protein conjugate vaccines. Am. Heart J. 147 (2004) 593-598
25. Roghmann M., Taylor K.L., Gupte A., Zhan M., Johnson J.A., Cross A., Edelman R., and Fattom A.I. Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia. J. Hosp. Infect. 59 (2005) 27-32
26. Shinefield H., Black S., Fattom A., Horwith G., Rasgon S., Ordonez J., Yeoh H., Law D., Robbins J.B., Schneerson R., Muenz L., Fuller S., Johnson J., Fireman B., Alcorn H., and Naso R. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N. Engl. J. Med. 346 (2002) 491-496
27. Shinefield H.R., and Black S. Prevention of Staphylococcus aureus infections: advances in vaccine development. Expert Rev. Vaccines 4 (2005) 669-676
28. Sompolinsky D., Samra Z., Karakawa W.W., Vann W.F., Schneerson R., and Malik Z. Encapsulation and capsular types in isolates of Staphylococcus aureus from different sources and relationship to phage types. J. Clin. Microbiol. 22 (1985) 828-834
29. Strommenger B., Kettlitz C., Weniger T., Harmsen D., Friedrich A.W., and Witte W. Assignment of Staphylococcus isolates to groups by spa typing, SmaI macrorestriction analysis, and multilocus sequence typing. J. Clin. Microbiol. 44 (2006) 2533-2540
30. von Eiff C., Becker K., Machka K., Stammer H., Peters G., and for the Study Group. Nasal carriage as a source of Staphylococcus aureus bacteremia. N. Engl. J. Med. 344 (2001) 11-16
31. Wanger A.R., Morris S.L., Ericsson C., Singh K.V., and LaRocco M.T. Latex agglutination-negative methicillin-resistant Staphylococcus aureus recovered from neonates: epidemiologic features and comparison of typing methods. J. Clin. Microbiol. 30 (1992) 2583-2588
32. Watts A., Ke D., Wang Q., Pillay A., Nicholson-Weller A., and Lee J.C. Staphylococcus aureus strains that express serotype 5 or serotype 8 capsular polysaccharides differ in virulence. Infect. Immun. 73 (2005) 3502-3511
33. Welch P.G., Fattom A., Moore Jr. J., Schneerson R., Shiloach J., Bryla D.A., Li X., and Robbins J.B. Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis. J. Am. Soc. Nephrol. 7 (1996) 247-253